Identification of risk factors for pancreatic pseudocysts formation, intervention and recurrence: a 15-year retrospective analysis in a tertiary hospital in China

Table 1 Univariate and multivariate regression analyses of risk factors associated with PPC formation

Variable	Univiarite analysis				Multivariate analysis
Variable	Total (n = 4379)	Group A (n = 759)	Group B (n = 3620)	P-value	OR (95% CI)	P-value
Age (years)	47.82 ± 15.31	47.33 ± 14.65	48.12 ± 15.74	0.523
Sex (male/female)	2788/1591	435/324	2253/1467	0.096
BMI	24.71 ± 4.85	24.28 ± 4.76	23.87 ± 5.13	0.329
Smoking (yes/no)	1343/3036	252/507	1091/2529	0.096
Comorbidity
Hypertension	425	78	347	0.559
Diabetes	505	83	412	0.724
Respiratory diseases	214	35	179	0.698
Liver diseases	147	34	113	0.061
Pancreatitis (acute/chronic)	3887/492	654/105	3233/387	0.013^a	5.822 (1.921-10.723)	0.006^a
Recurrent pancreatitis (yes/no)	861/3518	143/616	718/2917	0.565
Symptoms
Pain	4334	748	3586	0.028^a	1.557 (0.891-3.425)	0.067
Fever	751	112	639	0.054
Etiology
Biliary	1923	354	1569	0.096
Alcoholic	785	163	622	0.005^a	6.332 (2.164-11.628)	0.031^a
Trauma	304	42	262	0.093
Hyperglycemia	342	49	293	0.126
Post ERCP	577	84	493	0.059
Idiopathic	448	67	381	0.161
Lab examination
Amylase (U/L)	859.37 ± 612.35	831.22 ± 579.28	864.19 ± 634.56	0.574
WBC (10⁹/L)	13.79 ± 7.36	14.58 ± 8.24	12.46 ± 7.10	0.218
CRP (mg/L)	82.63 ± 28.52	86.48 ± 32.67	78.44 ± 26.36	0.227
TBIL (umol/L)	52.21 ± 33.62	54.37 ± 36.27	51.46 ± 31.70	0.232
IPN (%)	337 (7.7)	78 (10.3)	259 (7.2)	0.003^a	4.253 (3.574-7.339)	0.021^a
Antibiotics (Yes/No)	3782/592	644/115	3138/477	0.152
Somatostatin (Yes/No)	4201/178	725/34	3476/144	0.525

ISSN: 1471-230X